NCT06167902

The Metabolic Effects of Ginseng Oligopeptide Preparation on Non- Alcoholic Fatty Liver Disease With Obesity: a Randomized Controlled Double-blind Trial

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 200 (estimated)
• Sponsor: Peking Union Medical College Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

To investigate the effect of ginseng oligopeptide on nonalcoholic fatty liver disease with obesity and clarify its intervention mechanism in theory, which will contribute to the prevention and treatment of non-alcoholic fatty liver more scientifically and effectively.The patients were randomly divided into two groups. One group of patients took ginseng oligopeptide orally, and the other group took placebo. The liver function, blood lipid, blood glucose, liver B ultrasound and other indicators were observed to further determine the efficacy.

Conditions

• Non-alcoholic Fatty Liver Disease

Interventions

Type	Name	Description
OTHER	Ginseng oligopeptide (Ginseng extract）	The experimental group was given ginseng oligopeptide preparation 1.2g per day orally.
OTHER	Maltodextrin	The control group was treated with placebo maltodextrin 1.2g/d

Timeline

• Start date: 2023-12-25
• Primary completion: 2024-12-25
• Completion: 2025-12-25
• First posted: 2023-12-13
• Last updated: 2023-12-13